Patents matching “cells”

US 6596275

Monocyte derived cells with immunosuppressive properties, process for their preparation and their uses in pharmaceutical compositions

I.D.M. Immuno-Designed Molecules · Granted Jul 22, 2003 · Expires Jul 17, 2023

US 6582725

Human PEA3 is a tumor suppressor for cancer cells

The Board of Regents of the University of Texas System · Granted Jun 24, 2003 · Expires Jun 19, 2023

US 6576465

Human bone accessory cells

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 10, 2003 · Expires Jun 5, 2023

US 6569995

Identification of a G protein-coupled receptor transcriptionally regulated by protein tyrosine kinase signaling in hematopoietic cells

The Regents of the University of California · Granted May 27, 2003 · Expires May 22, 2023

US 6544972

Methods of limiting apoptosis of cells

Regents of the University of Minnesota · Granted Apr 8, 2003 · Expires Apr 3, 2023

US 6534261

Regulation of endogenous gene expression in cells using zinc finger proteins

Sangamo Biosciences, Inc. · Granted Mar 18, 2003 · Expires Mar 13, 2023

US 6521615

Diagnosing an animal for pyrophosphate gout, osteoporosis, or osteoarthritis by assaying intracellular pyrophosphate content in peripheral blood cells

The Regents of the University of California · Granted Feb 18, 2003 · Expires Feb 13, 2023

US 6491908

Selective elimination of T cells that recognize specific preselected targets

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 10, 2002 · Expires Dec 5, 2022

US 6489165

Chondrocyte-like cells useful for tissue engineering and methods

The Regents of the University of California · Granted Dec 3, 2002 · Expires Nov 28, 2022

US 6485722

Method for selective engraftment of drug-resistant hematopoietic stem cells

Regents of the University of Minnesota · Granted Nov 26, 2002 · Expires Nov 21, 2022

US 6479286

Methods and compositions for making dendritic cells from expanded populations of monocytes and for activating T cells

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 12, 2002 · Expires Nov 7, 2022

US 6468537

Localization of major peptide autoepitopes for nucleosome specific T cells of systemic lupus erythematosus

The Board of Trustees of Northwestern University · Granted Oct 22, 2002 · Expires Oct 17, 2022

US 6451316

Methods for generating antigen-reactive T cells in vitro

University of Connecticut Health Center · Granted Sep 17, 2002 · Expires Sep 12, 2022

US 6448045

Inducing insulin gene expression in pancreas cells expressing recombinant PDX-1

The Regents of the University of California · Granted Sep 10, 2002 · Expires Sep 5, 2022

US 6429009

Composition and method of imparting resistivity to HIV superinfection to cells

del Monte Tabor GenEra S.p.A. · Granted Aug 6, 2002 · Expires Aug 1, 2022

US 6410320

Method and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 25, 2002 · Expires Jun 20, 2022

US 6410029

2-methoxyestradiol-induced apoptosis in cancer cells

The Board of Regents of the University of Texas System · Granted Jun 25, 2002 · Expires Jun 20, 2022

US 6399362

Electrospraying apparatus and method for introducing material into cells

Regents of the University of Minnesota · Granted Jun 4, 2002 · Expires May 30, 2022

US 6399372

Monocyte derived cells with immunostimulating properties, their preparation and uses

I.D.M. IMMUNO-DESIGNED · Granted Jun 4, 2002 · Expires May 30, 2022

US 6399368

Secretion of T cell receptor fragments from recombinant Escherichia coli cells

The Board of Regents of the University of Texas System · Granted Jun 4, 2002 · Expires May 30, 2022

US 6395712

Sensitization of HER-2/neu overexpressing cancer cells to chemotherapy

The Board of Regents of the University of Texas System · Granted May 28, 2002 · Expires May 23, 2022

US 6375946

Enhanced activation of natural killer cells using an NK cell activator and a hydrogen peroxide scavenger or inhibitor

Maxim Pharmaceuticals, Inc. · Granted Apr 23, 2002 · Expires Apr 18, 2022

US 6368596

Compositions and methods for homoconjugates of antibodies which induce growth arrest or apoptosis of tumor cells

The Board of Regents of the University of Texas System · Granted Apr 9, 2002 · Expires Apr 4, 2022

US 6358736

Method for increasing the antigen presenting ability of leukemia cells

The United States of America, as represented by the Department of Health and Human Services · Granted Mar 19, 2002 · Expires Mar 14, 2022